Pharmacokinetics of Tamoxifen and Its Major Metabolites and the Effect of the African Ancestry Specific CYP2D617 Variant on the Formation of the Active Metabolite Endoxifen
dc.article.end-page | 16 | en |
dc.article.start-page | 1 | en |
dc.citation.doi | 10.3390/JPM13020272 | en |
dc.contributor.author | C R Kanji | en |
dc.contributor.author | G Nyabadza | en |
dc.contributor.author | C Nhachi | en |
dc.contributor.author | Collen Masimirembwa | en |
dc.date.accessioned | 2024-07-23T05:57:48Z | |
dc.date.available | 2024-07-23T05:57:48Z | |
dc.faculty | FACULTY OF HEALTH SCIENCES | en |
dc.identifier.citation | WOS | en |
dc.identifier.uri | https://hdl.handle.net/10539/39331 | |
dc.journal.title | Pharmacokinetics of Tamoxifen and Its Major Metabolites and the Effect of the African Ancestry Specific CYP2D617 Variant on the Formation of the Active Metabolite Endoxifen | en |
dc.journal.volume | 13 | en |
dc.title | Pharmacokinetics of Tamoxifen and Its Major Metabolites and the Effect of the African Ancestry Specific CYP2D617 Variant on the Formation of the Active Metabolite Endoxifen | en |
dc.type | Journal Article | en |